|

Umbilical Cord Mesenchymal Stem Cells Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: UC-MSCs

Pipeline

Phase 1/2: 1

Top Sponsors

  • PT. Prodia Stem Cell Indonesia1

Indications

Other1 trial

Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.